Drug Overdose – A Hidden Hazard of Obesity

Report of the Royal College of Physicians. Obesity. J R Coll Physicians London 1983; 17: 5–65

Von Hoff D.D. , Maxwell W.L. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 91: 710–17

Benjamin R.S. , Wiernik P.H. , Bachur N.R. . Adriamycin chemotherapy – efficacy, safety and pharmacologic basis of an intermittent single high-dosage schedule. Cancer 1974; 33: 19–27

Brenner D.E. , Wiernik P.H. , Wesley M. , Bachur N.R. . Acute doxorubicin toxicity. Cancer 1984; 53: 1042–8

Benjamin R.S. , Riggs C.E. , Bachur N.R. . Pharmacokinetics and metabolism of Adriamycin in man. Clin Pharmacol Ther 1973; 14: 592–600

Lee Y.T.N. , Chan K.K. , Harris P.A. , Cohen J.L. . Distribution of Adriamycin in cancer patients. Cancer 1980; 45: 2231–9

Devine B.J. . Gentamicin therapy. Drug Intell Clin Pharm 1974; 8: 650–5